MUC16 and neoplasm: For example, REGN4018 targeting MUC16/CD3 and MUC16/CD28 targeting MUC16 are both bispecific antibodies binding to MUC16 proximal membrane region (MUC16△), which can effectively bind MUC16 and induce T cells to redirect to kill tumor cells.